Simple and validated method to quantify lacosamide in human breast milk and plasma using UPLC/MS/MS and its application to estimate drug transfer into breast milk
Tóm tắt
Epilepsy is a common neurological disorder. Lacosamide is a third-generation antiepileptic drug used to treat partial-onset seizures. Limited information is currently available on the transfer of lacosamide to breast milk. To facilitate studies on the safety of lacosamide use during breastfeeding, we aimed to develop a method to quantify lacosamide in human breast milk and plasma using ultra-performance liquid chromatography/tandem mass spectrometry. Fifty microliters of breast milk or plasma was used, and samples were prepared by protein precipitation using methanol containing lacosamide-d3 as an internal standard (IS). Chromatography was performed using an ACQUITY HSS T3 column with an isocratic flow of 10 mM ammonium acetate solution/methanol (70:30, v/v). Lacosamide and IS were detected by multiple reaction monitoring in positive ion electrospray mode. The run time was 3.5 min. Calibration curves were linear and in the range of 0.5 to 100 ng/mL both in breast milk and plasma. The validation assessment indicated that precision, accuracy, matrix effects, selectivity, dilution integrity, and stability were acceptable. The developed method was successfully applied to quantify lacosamide in breast milk and plasma obtained from a volunteer who had been orally administered lacosamide twice a day (100 mg × 2). Relative infant dose of lacosamide was estimated to be 14.6% in breast milk at five time points. We developed a simple and robust method to quantify of lacosamide in human breast milk and plasma. This method could be useful for in future studies investigating the safety of lacosamide use during breastfeeding.
Tài liệu tham khảo
Victora CG, Bahl R, Barros AJ, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–90. https://doi.org/10.1016/S0140-6736(15)01024-7.
Schirm E, Schwagermann MP, Tobi H, de Jong-van den Berg LT. Drug use during breastfeeding. a survey from the Netherlands. Eur J Clin Nutr. 2004;58(2):386–90. https://doi.org/10.1038/sj.ejcn.1601799.
Verstegen RHJ, Anderson PO, Ito S. Infant drug exposure via breast milk. Br J Clin Pharmacol. 2022;88(10):4311–27. https://doi.org/10.1111/bcp.14538.
Shawahna R, Zaid L. Concentrations of antiseizure medications in breast milk of lactating women with epilepsy: A systematic review with qualitative synthesis. Seizure. 2022;98:57–70. https://doi.org/10.1016/j.seizure.2022.03.017.
Birnbaum AK, Meador KJ, Karanam A, et al. Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy. JAMA Neurol. 2020;77(4):441–50. https://doi.org/10.1001/jamaneurol.2019.4443.
Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Res. 2015;110:189–205. https://doi.org/10.1016/j.eplepsyres.2014.11.021.
Baulac M, Rosenow F, Toledo M, et al. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial [published correction appears in Lancet Neurol. 2017 Feb;16(2):102]. Lancet Neurol. 2017;16(1):43–54. https://doi.org/10.1016/S1474-4422(16)30292-7.
Drugs and Lactation Database (LactMed), Bethesda (MD): National Library of Medicine (US), 2006 Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/. [Last accessed: March 20, 2023]
Ylikotila P, Ketola RA, Timonen S, Malm H, Ruuskanen JO. Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Reprod Toxicol. 2015;57:204–6. https://doi.org/10.1016/j.reprotox.2015.07.068.
Zarubova J, Kremlackova V, Borecka K, et al. Plasma and breast milk levels of lacosamide before, during and post pregnancy. Epilepsia. 2016;57:69. [Abstract].
Kohn E, Dinavitser N, Gandelman-Marton R, et al. Lacosamide levels in blood and breast milk during pregnancy and lactation: a case report. Reprod Toxicol. 2020;97:9–10.
Monfort A, Jutras M, Martin B, et al. New data on the transfer of untested medication into breast milk. Birth Defects Res. 2021;113:831 [Abstract].
Landmark CJ, Rektorli L, Burns ML, Revdal E, Johannessen SI, Brodtkorb E. Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation. Epileptic Disord. 2021;23(2):426–31. https://doi.org/10.1684/epd.2021.1273.
Kestelyn C, Lastelle M, Higuet N, et al. A simple HPLC-UV method for the determination of lacosamide in human plasma. Bioanalysis. 2011;3(22):2515–22. https://doi.org/10.4155/bio.11.261.
Kim SJ, Koo TS, Ha DJ, et al. Liquid chromatography-tandem mass spectrometry for quantification of lacosamide, an antiepileptic drug, in rat plasma and its application to pharmacokinetic study. Biomed Chromatogr. 2012;26(3):371–6. https://doi.org/10.1002/bmc.1668.
Korman E, Langman LJ, Jannetto PJ. High-throughput method for the quantification of lacosamide in serum using ultrafast SPE-MS/MS. Ther Drug Monit. 2015;37(1):126–31. https://doi.org/10.1097/FTD.0000000000000115.
Deeb S, McKeown DA, Torrance HJ, Wylie FM, Logan BK, Scott KS. Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases. J Anal Toxicol. 2014;38(8):485–94. https://doi.org/10.1093/jat/bku070.
Payto D, Foldvary-Schaefer N, So N, Bruton M, Wang S. A sensitive and rapid method for quantification of lacosamide and desmethyl lacosamide by LC-MS/MS. Bioanalysis. 2014;6(23):3161–8. https://doi.org/10.4155/bio.14.158.
Yang HS, Edinboro L. Therapeutic drug monitoring of lacosamide by LC-MS/MS. Methods Mol Biol. 2019;1872:67–73. https://doi.org/10.1007/978-1-4939-8823-5_7.
Zhang YY, Xia Y, Guo HL, et al. An LC-ESI-MS/MS assay for the therapeutic drug monitoring of 15 antiseizure medications in plasma of children with epilepsy. Biomed Chromatogr. 2022;36(12):e5484. https://doi.org/10.1002/bmc.5484.
Kuhn J, Knabbe C. Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Talanta. 2013;110:71–80. https://doi.org/10.1016/j.talanta.2013.02.010.
DʼUrso A, Cangemi G, Barco S, Striano P, DʼAvolio A, de Grazia U. LC-MS/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device. Ther Drug Monit. 2019;41(3):331–9. https://doi.org/10.1097/FTD.0000000000000600.
Möller I, Held K, Klimpel D, Nadulski T, Dufaux B. Development and validation of an LC-MS/MS method for relevant drugs in epilepsy patients using dried blood spots. Biomed Chromatogr. 2021;35(9):e5130. https://doi.org/10.1002/bmc.5130.
Qiu E, Yu L, Liang Q, Wen C. Simultaneous determination of lamotrigine, oxcarbazepine, lacosamide, and topiramate in rat plasma by ultra-performance liquid chromatography-tandem mass spectrometry. Int J Anal Chem. 2022;2022:1838645. https://doi.org/10.1155/2022/1838645.
Monfort A, Jutras M, Martin B, Boucoiran I, Ferreira E, Leclair G. Simultaneous quantification of 19 analytes in breast milk by liquid chromatography-tandem mass spectrometry (LC-MS/MS). J Pharm Biomed Anal. 2021;204:114236. https://doi.org/10.1016/j.jpba.2021.114236.
Krasowski MD. Therapeutic drug monitoring of the newer anti-epilepsy medications. Pharmaceuticals (Basel). 2010;3(6):1909–35. https://doi.org/10.3390/ph3061909.
Cawello W. Clinical pharmacokinetic and pharmacodynamic profile of lacosamide. Clin Pharmacokinet. 2015;54(9):901–14. https://doi.org/10.1007/s40262-015-0276-0.
Anderson PO, Sauberan JB. Modeling drug passage into human milk. Clin Pharmacol Ther. 2016;100(1):42–52. https://doi.org/10.1002/cpt.377.
Patsalos PN, Zugman M, Lake C, James A, Ratnaraj N, Sander JW. Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: a comparison of free non-protein-bound concentrations. Epilepsia. 2017;58(7):1234–43. https://doi.org/10.1111/epi.13802.
Dean M, Stock B, Patterson RJ, Levy G. Serum protein binding of drugs during and after pregnancy in humans. Clin Pharmacol Ther. 1980;28:253–61. https://doi.org/10.1038/clpt.1980.158.